Development of novel mechanisms for housing, handling, and remote monitoring of common marmosets at animal biosafety level 3.

The use of common marmosets as an alternative non-human primate model for infectious disease research using BSL-3 viruses such as Rift Valley fever virus (RVFV) presents unique challenges with respect to housing, handling, and safety. Subject matter experts from veterinary care, animal husbandry, biosafety, engineering, and research were consulted to design a pilot experiment using marmosets infected with RVFV. This paper reviews the caging, handling, and safety-related adaptations and modifications that were required to humanely utilize marmosets as a model for high-hazard BSL-3 viral diseases.

Guidelines for Biosafety Training Programs for Workers Assigned to BSL-3 Research Laboratories.

The Guidelines for Biosafety Training Programs for Workers Assigned to BSL-3 Research Laboratories were developed by biosafety professionals who oversee training programs for the 2 national biocontainment laboratories (NBLs) and the 13 regional biocontainment laboratories (RBLs) that participate in the National Institute of Allergy and Infectious Diseases (NIAID) NBL/RBL Network. These guidelines provide a general training framework for biosafety level 3 (BSL-3) high-containment laboratories, identify key training concepts, and outline training methodologies designed to standardize base knowledge, understanding, and technical competence of laboratory personnel working in high-containment laboratories. Emphasis is placed on building a culture of risk assessment-based safety through competency training designed to enhance understanding and recognition of potential biological hazards as well as methods for controlling these hazards. These guidelines may be of value to other institutions and academic research laboratories that are developing biosafety training programs for BSL-3 research.

Decontamination and digestion of infectious animal waste using a tissue dissolver in an animal biosafety level 3 facility.

Alkaline hydrolysis-based tissue dissolvers (TDs) are commercially available tools for the digestion and decontamination of infectious animal waste. The authors carried out a series of experiments to verify whether the TD in their facility completely digested animal carcasses and inactivated infectious agents. Using the manufacturer's recommended cycle parameters, the TD inactivated a high concentration of chemically resistant bacterial spores used as a surrogate for the infectious agents in use in the facility. Animal tissues were completely digested into a non-infectious liquid effluent that could be disposed of directly to the sanitary sewer. Reducing the cycle time by 50% still inactivated all spores, although a small amount of tissue remained undigested. The authors recommend that each facility carry out its own experiments to verify the efficacy of a TD before use, given that the design and style of TD as well as the composition of the tissue load is likely to vary between facilities.